In an effort to lower the cost of necessary drugs, Aurolab created its
Pharma Division in 1997 with the goal of becoming a
constant and consistent source of high quality ophthalmic
pharmaceuticals.
Aurolab has
developed a wide range of ophthalmic drugs that are cost
effective, especially in developing countries. The modern state-of-the-art pharmaceutical formulation facility produces
anti-infective, anti-fungal, anti-viral, anti-allergics,
anti-inflammatory agents, glaucoma agents, mydriatics,
cycloplegics, ophthalmic dyes, ocular lubricants and surgical
aids.
Aurolab has
received the prestigious CE mark certification for HPMC and
Trypan Blue, Indocyanine Green, Perfluoro-n-octane and Silicon Oil.
The World Health Organization (WHO) Good Manufacturing
Practices (GMP) certification was awarded to the division,
confirming that all AUROLAB pharmaceutical products are made in
compliance with international standards.
